Acetyl-(Nle4,Asp5,D-2-Nal7,Lys10)-cyclo-α-MSH (4-10) amide combines multiple modifications within a cyclic framework, altering polarity, aromaticity, and backbone rigidity. Its capped and amidated termini enhance stability. The peptide supports melanocortin-binding and structural studies. Applications include peptide engineering, motif mapping, and conformational analysis.
CAT No: M2715
CAS No:168482-23-3
Synonyms/Alias:Shu-9119;CHEMBL3422426;168482-23-3;(3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-9-(naphthalen-2-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxamide;SHU9119 (trifluoroacetate salt);GGYWLZFXFKFWKL-XOJVSUSESA-N;GTPL1325;BDBM50080576;AKOS024457620;FA109130;L-Lysinamide,N-acetyl-L-norleucyl-L-a-aspartyl-l-histidyl-3-(2-naphthalenyl)-D-alanyl-L-arginyl-L-tryptophyl-,(2(R)7)-lactam;N-Acetyl-L-norleucyl-L-a-aspartyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-L-arginyl-L-tryptophyl-L-lysinamide-(2,7) -lactam;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.